New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 26, 2013
20:30 EDTSCMPSucampo receives $10M milestone payment from Takeda
Sucampo Pharmaceuticals announced that it has received a $10M milestone payment from Takeda, pursuant to the existing collaboration and license agreement between SPI and Takeda. The milestone payment was triggered by the commercial launch of AMITIZA in the United States for the treatment of opioid-induced constipation in adult patients with chronic, non-cancer pain. This is the third indication for AMITIZA.
News For SCMP From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
May 20, 2015
09:13 EDTSCMPSucampo expects approvals for AMITIZA in additional European markets in 1H15
Subscribe for More Information
09:08 EDTSCMPSucampo backs FY15 EPS 55c-65c, consensus 63c
Subscribe for More Information
07:21 EDTSCMPUBS to hold a conference
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use